Fairmount Funds Management LLC
Top Portfolio Positions
12 positions ·
$1,259,347,182 total
· as of Dec 31, 2025
| Ticker | Company | Shares | Value (USD) | % of Portfolio |
|---|---|---|---|---|
| COGT |
Cogent Biosciences, Inc.
|
9,003,418 | $319,801,407 | 25.39% |
| APGE |
Apogee Therapeutics, Inc.
|
2,048,647 | $154,631,875 | 12.28% |
| SYRE |
Spyre Therapeutics, Inc.
|
4,018,101 | $131,632,988 | 10.45% |
| VRDN |
Viridian Therapeutics, Inc.\DE
|
3,914,458 | $121,817,932 | 9.67% |
| ORKA |
Oruka Therapeutics, Inc.
|
3,705,262 | $112,306,491 | 8.92% |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
2,137,191 | $88,073,641 | 6.99% |
| ZBIO |
Zenas BioPharma, Inc.
|
2,209,025 | $80,209,697 | 6.37% |
| NUVL |
Nuvalent, Inc.
|
727,563 | $73,185,562 | 5.81% |
| JBIO |
Jade Biosciences, Inc.
|
4,553,494 | $70,260,412 | 5.58% |
| ELVN |
Enliven Therapeutics, Inc.
|
3,711,444 | $57,156,237 | 4.54% |
Portfolio Trend
Holdings in JBIO
Export CSVShares Held
Position Value (USD)
3 of 3 shown
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $70,260,412 | 4,553,494 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $27,791,775 | 3,220,368 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $32,171,476 | 3,220,368 | Shares | Sole | 2025-08-14 | |
| No quarters match your search. | ||||||